NCT05080244View on ClinicalTrials.gov

WHO COVID-19 - Evaluation of the Efficacy of Probiotics to Reduce the Occurrence of Long COVID

NACompletedINTERVENTIONAL
Enrollment

618

Participants

Timeline

Start Date

October 28, 2021

Primary Completion Date

December 4, 2022

Study Completion Date

December 4, 2022

Conditions
COVID-19
Interventions
DIETARY_SUPPLEMENT

Probiotics

2 strains 10x10\^9 UFC/capsule

DIETARY_SUPPLEMENT

Placebo

Potato starch and magnesium stearate

Trial Locations (1)

J1H 5N4

CIUSSS de L'Estrie-CHUS Hospital, Sherbrooke

Sponsors
All Listed Sponsors
collaborator

Lallemand Health Solutions

INDUSTRY

lead

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

OTHER